A recent study published in The New England Journal of Medicine found that adding blinatumomab to standard chemotherapy significantly improved disease-free survival in children with standard-risk B-cell acute lymphoblastic leukemia, reducing relapse rates and especially decreasing bone marrow relapse.
A recent study on familial Mediterranean fever revealed that nearly 56% of heterozygous patients who stopped colchicine therapy sustained remission with lower levels of specific biomarkers, highlighting the potential of personalized treatment for FMF patients.
A recent study reveals that dupilumab can reduce infection rates in young children with moderate-to-severe atopic dermatitis, offering potential long-term benefits for this patient population.
A recent study comparing telemedicine and in-person visits in pediatric primary care found lower medication prescribing and diagnostic orders with telemedicine, but also slightly increased follow-up and emergency department visits.
A recent review finds that moisturizers, commonly used in dermatitis care, may lead to adverse effects in children with eczema, emphasizing the need for moderation and personalized recommendations for their use. Published in the Journal of the American Academy of Dermatology.
A recent analysis reveals widening life expectancy disparities in the U.S., with American Indian and Alaska Native participants in the West experiencing a significant decline to just 63.6 years by 2021.